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Abstract
In recent years, continuous glucose monitoring (CGM) has been introduced and used in clinical diabetic research.
Authors have investigated research about Low Carbohydrate Diet (LCD) and Calorie Restriction (CR) and developed
medical and social LCD movement through Japan LCD Promotion Association (JLCDPA). In this study, a case with
remarkable improving effect for change from CR to LCD is presented using CGM. The case is 41 years-old female
with type 2 diabetes mellitus (T2DM). She was newly diagnosed as T2DM with HbA1c 11.0%, glucose >400 mg/dL,
BMI 26.0, AST 30 IU/mL, Hb 16.3 g/dL. She was given CR meal with 60% carbohydrate on day 1 to 4, and LCD
meal with 12% carbohydrate on day 5 to 7. Daily profile of blood glucose showed 200-400 mg/dL in day 1-4,
160-240 mg/dL on day 5 and 110-150 mg/dL on day 7. FreeStyle Libre (Abbott, USA) has been valid and useful
medical apparatus for monitoring the the detailed fluctuation of blood glucose. Blood glucose value was immediately
decreased just after starting LCD, and the short-term effect of the LCD was found. These results would become
basal and reference data and contribute to the development of future research.
Keywords: FreeStyle libre; Continuous glucose monitoring; Low
carbohydrate diet; Glucose variability; Japan LCD promotion
association; Calorie restriction
Abbreviations: CGM: Continuous Glucose Monitoring; LCD: Low
Carbohydrate Diet; T2DM: Type 2 Diabetes Mellitus; CR: Calorie
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Introduction
In recent years, the adequate treatment and management for
diabetes has become an important problem in medical practice and
research [1]. Observing the diabetic situation in the world, the
prevalence of diabetes has been increasing year by year [2]. Among
them, diet therapy is the fundamental therapy for diabetes, and various
dietary therapies have been reported so far [3]. They include variety
types of diet, such as low-carbohydrate diet, low-fat diet, vegetarian
diet, high protein diet, Mediterranean dietary pattern, Paleolithic diet,
low-glycemic index/load diet.
Including these reports and related papers, the comparison with CR
or LCD has been often investigated, when adequate diabetic nutrition
has been discussed [4]. Historically, CR has been known for standard
diabetic nutritional therapy. However, LCDs Bernstein and colleagues
have introduced and started LCD in early period [5]. Afterwards, the
efficacy of LCD has been reported by the investigators of Dietary
Intervention Randomized Controlled Trial (DIRECT) Group and
others [6,7]. Thus, the diet method of LCD has been spread in
European and North American countries [8].
In Japan, Ebe et al. firstly reported the medical application of LCD
[9]. After that, the authors have reported markedly high value of blood
ketone bodies in fetuses, placenta, neonates, and pregnant women and
discussed the physiological role of ketone bodies [10]. Following this,
we have continued clinical research on LCD for obesity, diabetes,
pregnant women, and various subjects [11,12]. Several reports have
been found about the clinical effectiveness of LCD [13,14].
Through continuing such our clinical studies, we experienced a case
with T2DM in which continuous glucose monitoring (CGM). Two
dietary regimens, CR and LCD were obtained and the detail glucose
variability was elucidated. The detail of them would be described in
this report.
Case Presentation
History of present illness
The patient enrolled in this study was 41 years-old female. She has
unremarkable past history or family history. She developed the
symptom of urinary incontinence for several days and consulted our
clinic. Urinalysis showed turbidity of the urine and increased WBC
suggesting urinary tract infection and cystitis. Furthermore, it showed
highly elevated glucose concentration and elevated protein, and
elevated occult blood, which strongly suggests the presence of diabetes
mellitus.
The patient was checked the routine examination of diabetes.
Postprandial blood glucose was more than 400 mg/dL, and HbA1c
value was 11.0%. She was diagnosed as type 2 diabetes mellitus
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Physicals and basal tests
On the first visit for the outclinic, her physicals was unremarkable,
and negative for vitals, heart, lung, abdomen and neurological
findings. Her body mass index (BMI) was 26.0 kg/m2. Chest X-ray and
Electrocardiogram (ECG) were unremarkable.
Biochemistry
The Data of the fundamental blood tests were revealed in the
following: AST 30 IU/mL, ALT 33 IU/mL, AlP 350 IU/mL (104-338),
total protein 7.6 g/dL, T-Bil 0.3 mg/dL, D-Bil 0.1 mg/dL, BUN 12
mg/dL, Cre 0.5 mg/dL, Na 135 mEq/L, K 3.9 mEq/L, Cl 98 mEq/L, T-
Cho 204 mg/dL, complete blood count; RBC 518 × 104/μl, Hb 16.3
g/dL, MCV 92 fL, WBC 12,250/μl, Fe 81 μg/dL, ferritin 105 ng/mL
(5-157).
Research Methods and Progress
In current study for blood glucose fluctuation, we used recently-
introduced apparatus, FreeStyle Libre [15]. It has been reliable
apparatus for Continuous Glucose Monitoring (CGM) worldwide [16].
It has been produced by Abbott Diabetes Care Inc. and been prevalent
in recent years [17].
Authors have investigated nutritional therapy using Low
Carbohydrate Diet (LCD) and also Calorie Restriction (CR) for years.
We have certain protocol for research meal for LCD and CR. CR has
60% of carbohydrate in calorie ratio, which is the standard Japanese
meal for diabetes by Japan Diabetes Association [18]. On the other
hand, LCD meal was selected 12% of carbohydrate in calorie ratio,
which has been called as super-LCD. It is from standard LCD meal by
Ebe et al. in Japan LCD Promotion Association (JLCDPA). In current
study, we have provided the patient the following standard protocol for
CR and LCD meals in our investigation:
• The patient has her regular meal as CR diet from day 1 to day 4,
• The meal time is regular at 0800h, 1200h and 1800h,
• She has super-LCD meal from day 5 to day 7,
• Daily profile of blood glucose was studied from day 1 to day 7.
The result of CGM by FreeStyle Libre for glucose variability was 
shown in Figure 1. Daily profile of blood glucose from day 1 to day 4 
showed almost between 200 mg/dL to 400 mg/dL. For these period, 
patient has CR meal. After that, she has changed to LCD meal from 
day 5 to day 7. Blood glucose value has decreased around 160 mg/dL 
to 240 mg/dL abruptly on day 5. Successively, blood glucose ranged 
about from 110 mg/dL to 150 mg/dL on day 7.
Discussion and Conclusion
CGM has been developed by medical and engineering inspection
techniques, and one of the CGM, FreeStyle Libre has been gained its
validity and credibility so far [19]. In particular, it was to reduce the
incidence of hypoglycemia in type 1 diabetes that CGM seemed to be
clinically very effective. In the DIAMOND Randomized Clinical Trial,
a result of HbA1c with low hypoglycemia was obtained [20]. It is also
applied to the patients with type 2 diabetes and other situations, and it
has been evaluated the usefulness of obtaining the glucose variability
[21]. For the development of CGM, Food and Drug Administration
(FDA) approved the management decisions about the insulin dose
from obtained CGM values [22].
Figure 1: Daily profile of blood glucose from day 1 to 7 using CGM, 
Calorie restriction (CR) in day 1 to day 4, Low carbohydrate diet 
(LCD) in day 5 to day 7.
Concerning the technical aspect of CGM, Updike et al. reported
formerly [23]. Successively, the electrodes were improved for
converting blood glucose level into electric signals. Then some CGM
experimental trials were shown [24]. The guideline of CGM was shown
by Clinical and Laboratory Standards Institute (CLSI) [25]. Further,
lots of research have been found concerning international
standardization. They include mean absolute relative deviation
(MARD) and precision absolute relative difference (PARD) [26,27].
FreeStyle Libre (Abbott, USA) has been evaluated for useful
examination tool for CGM with sensor-based method for glucose
monitoring [28].
Historically, authors and co-researcher have developed LCD in
Japan. Dr. Ebe initiated and reported LCD in Japan and continued
medical practice of LCD [9]. We have also established the Japan LCD
Promotion Association (JLCDPA) and developed LCD movement with
books, seminars and reports in medical societies for years [11].
As a matter of fact, the author previously had diabetes sustaining the
HbA1c value more than 9%. At that time, I have obtained the medical
information for LCD and tried and continued LCD. Then, successfully,
weight reduction of 15 kg were found. Furthermore, HbA1c value
decreased to 5%, and both high blood pressure and fat liver were all
relieved. According to this dramatic change and remarkable effect, the
author has decided to apply LCD in the field of obstetrics and
gynecology (OB/GYN) [11]. After that, the author have applied LCD
to gestational diabetes mellitus, diabetic pregnant woman
management, and infertility treatment in OB/GYN, and showed
breakthrough results until now [29]. We have reported clinical studies
in several medical association, and developed LCD socially with some
textbooks.
Concerning this activity for developing LCD, it is true that there
were moderate objections at the beginning. However, medical
misunderstanding has been gradually smaller about LCD and
hyperketonemia, leading to widespread of LCD.
At present, several incorrect explanations have been found in two
points. One is the content ratio of carbohydrates with respect to
carbohydrate restriction. In our research protocol, 12%, 26% and 40%
of carbohydrates are defined as super LCD, standard LCD, petite LCD
respectively [30]. In general medical research field, however, the
standard of carbohydrate inclusion in LCD is not determined.
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Therefore, there are many papers under different conditions, and
various evaluations are observed [4]. Another problem is that there are
several situations concerning hyperketonemia, such as three typical
situations. They are:
• Pathological cases of diabetic coma,
• Insufficient calorie intake and/or dehydration,
• Fat in the body has been burning due to carbohydrate restriction.
Medical physicians and staffs tend to be confused concerning these
situations [31,32].
Current data can be analyzed in detail. As to the blood glucose
between preprandial and postprandial blood glucose from day 1 to day
4, it increased from about 190 mg/dL to 390 mg/dL with approximately
rise in 200 mg/dL. It has been considered as a standard that an increase
of 3 mg/dL is observed after ingestion of 1 g of carbohydrate.
Consequently, blood glucose seemed to be increased due to ingestion
of about 70 g of carbohydrate. Moreover, it is inferred that intake of the
same amount of carbohydrates on day 2, 3, and 4 resulted in almost
similar daily fluctuation of blood glucose.
On the other hand, when LCD meal was administered from day 5 to
day 7, the difference between preprandial and postprandial glucose
was less than 60 mg/dL. It is inferred that approximately 20 g of
carbohydrate was contained in each meal. Further, the difference
before and after the meal decreased from day 5, day 6 to day 7. The
fluctuation range of blood sugar on day 7 were smaller from 110 mg/dl
to 150 mg/dL, which is almost the same level as that in normal people.
Thus, it is suggested that the LCD can lower blood glucose variability
from the first day, with remarkable efficacy for decreasing blood
glucose [33].
In summary, we could monitor the detailed fluctuation of blood
glucose by using CGM, when diet was changed from CR to LCD. As a
result, the blood glucose was immediately decreased just after starting
LCD, and the short-term effect of the LCD was proved. These results
will become basal and reference data and contribute to the
development of future research.
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